IMBiologics

로고

About us
Core Technology
Pipeline
- Overview
- IMB-101/102
- IMB-201
- IMB-301
- IMB-401
Media Room
- Notice
- News
- Gallery
Careers
- Culture
- Recruiting Information

언어선택 ENG

KOR ENG

전체메뉴

About us
Core Technology
Pipeline
- Overview
- IMB-101/102
- IMB-201
- IMB-301
- IMB-401
Media Room
- Notice
- News
- Gallery
Careers
- Culture
- Recruiting Information

Gallery

Innovative Medicines based on
ImmunoModulatory Biologics

Media Room
About us Core Technology Pipeline Media Room Careers
Gallery
Notice News Gallery

Total2

IMBiologics, MOU with Canton Biologics

2023-10-31
IMBiologics

2022-04-06

Total

President(CEO) : Gyongsik Ha
260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea